Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Blackstone commits up to $1.5B for R&D of Pfizer's ex-Metsera GLP-1

Pfizer has secured up to $1.5 billion from the investment group Blackstone Life Sciences to help pay for the development of its obesity candidate berobenatide. The co-funding agreement will see that cash come from funds ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 12 November →